Abstract
Early cancer non-invasive diagnosis is a leading medical topic worldwide due to the threat to human life and the high death rate of this disease. Light-absorption-based thermophotonic diagnostic imaging is well positioned for this challenge thanks to its speed, safety, and high molecular contrast advantages. In this Letter, an enhanced truncated-correlation photothermal coherence tomography (TC-PCT) imaging modality is presented for early in vivo tumor detection and tested using a nude mouse thigh. Compared with conventional TC-PCT, the enhanced imaging modality was found to exhibit higher contrast that contributed to the precise measurement of the size and shape of the detected tumor. The experimental results were validated following histological analysis from hematoxylin and eosin staining. This increased contrast advantage gives rise to possible clinical applications in early tumor detection and treatment and in monitoring the effects of anti-tumor drugs.
| Original language | English |
|---|---|
| Pages (from-to) | 675-678 |
| Number of pages | 4 |
| Journal | Optics Letters |
| Volume | 44 |
| Issue number | 3 |
| DOIs | |
| State | Published - 1 Feb 2019 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Truncated-correlation photothermal coherence tomography derivative imaging modality for small animal in vivo early tumor detection'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver